DE60032161D1 - P-glycoproteine und ihre verwendungen - Google Patents

P-glycoproteine und ihre verwendungen

Info

Publication number
DE60032161D1
DE60032161D1 DE60032161T DE60032161T DE60032161D1 DE 60032161 D1 DE60032161 D1 DE 60032161D1 DE 60032161 T DE60032161 T DE 60032161T DE 60032161 T DE60032161 T DE 60032161T DE 60032161 D1 DE60032161 D1 DE 60032161D1
Authority
DE
Germany
Prior art keywords
dog
pgp
glycoproteins
inhibitors
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032161T
Other languages
English (en)
Inventor
J Stocker
T Steimel-Crespi
L Crespi
C Reif
J Patten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Application granted granted Critical
Publication of DE60032161D1 publication Critical patent/DE60032161D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60032161T 1999-09-28 2000-09-28 P-glycoproteine und ihre verwendungen Expired - Lifetime DE60032161D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15651099P 1999-09-28 1999-09-28
PCT/US2000/026767 WO2001023540A2 (en) 1999-09-28 2000-09-28 P-glycoproteins and uses thereof

Publications (1)

Publication Number Publication Date
DE60032161D1 true DE60032161D1 (de) 2007-01-11

Family

ID=22559872

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032161T Expired - Lifetime DE60032161D1 (de) 1999-09-28 2000-09-28 P-glycoproteine und ihre verwendungen

Country Status (7)

Country Link
EP (1) EP1220911B1 (de)
JP (2) JP2003510071A (de)
AT (1) ATE346924T1 (de)
AU (1) AU785363B2 (de)
CA (1) CA2384981A1 (de)
DE (1) DE60032161D1 (de)
WO (1) WO2001023540A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2659877T3 (es) * 2000-06-05 2018-03-19 The Brigham And Women's Hospital, Inc. Un gen que codifica un homólogo de glicoproteína p humana multifármaco-resistente en el cromosoma 7p15-21 y usos del mismo
JP2005503764A (ja) * 2001-03-19 2005-02-10 ジェンテスト・コーポレーション Ｐ糖タンパク質およびその使用
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
ES2796111T3 (es) 2008-11-14 2020-11-25 Brigham & Womens Hospital Inc Métodos terapéuticos relacionados con células madre cancerosas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024613A1 (en) * 1992-05-22 1993-12-09 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes
US5830697A (en) * 1997-01-21 1998-11-03 The Board Of Trustees Of The Leland Stanford Junior University P-glycoprotein mutant resistant to cyclosporin modulation

Also Published As

Publication number Publication date
ATE346924T1 (de) 2006-12-15
EP1220911A2 (de) 2002-07-10
JP2003510071A (ja) 2003-03-18
WO2001023540A2 (en) 2001-04-05
WO2001023540A3 (en) 2001-10-18
AU785363B2 (en) 2007-02-01
EP1220911B1 (de) 2006-11-29
AU7732700A (en) 2001-04-30
CA2384981A1 (en) 2001-04-05
JP2012061008A (ja) 2012-03-29

Similar Documents

Publication Publication Date Title
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
CY1106708T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
ATE377597T1 (de) Anilinochinazoline als protein-tyrosin- kinasehemmer
PT966465E (pt) Inibidores do enzima imfdh
DE60021282D1 (de) Carbamat-derivate als muscarin-rezeptor antonisten
ATE469151T1 (de) Pyrrolopyridinderivate als proteinkinaseinhibitoren
WO2002089738A3 (en) Proteomimetic compounds and methods
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
ATE300533T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
ATE312090T1 (de) 4-(piperidyl- und pyrrolidyl-alkyl-ureido)- chinoline als urotensin ii rezeptor antagonisten
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
SE0202598D0 (sv) Alpha-7 Nicotinic receptor agonists and statins in combination
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
WO2006047728A3 (en) Bmp gene and fusion protein
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
DE60032161D1 (de) P-glycoproteine und ihre verwendungen
WO2002074048A3 (en) P-glycoproteins and uses thereof
AU2003259750A8 (en) Methods and compositions for targeting secretory lysosomes
ATE397663T1 (de) Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen
MXPA05006587A (es) Compuestos de tiazol como derivados de antagonistas del receptor de la integrina.
IL151211A0 (en) Compositions useful for regulating parkin gene activity
WO2005079541A3 (en) Terephthalamide peptidomimetic compounds and methods
ITFI20030238A1 (it) Peptidi ciclici antagonisti dell'urotensina-ii

Legal Events

Date Code Title Description
8332 No legal effect for de